Following our recent conversation with Dr. Robin Carhart-Harris on the neuroscience of SSRIs and psychedelics, this bonus episode takes the next step—focusing on clinical realities, tapering strategies, and patient safety.
Dr. Dave Rabin—a board-certified psychiatrist, neuroscientist, and co-founder of Apollo Neuro—joins Paul F. Austin for a candid, protocol-driven conversation. Together, they unpack why combining SSRIs with psychedelics can be dangerous, how to safely taper with support tools like ketamine and CBDA, and how to prepare clients for deeper psychedelic work.
If you’re a facilitator, therapist, or simply someone navigating antidepressants and interested in microdosing, this episode offers practical, medically-grounded insights.
Dr. Dave Rabin is a board-certified psychiatrist, neuroscientist, and co-founder of Apollo Neuro. He specializes in treatment-resistant depression, PTSD, and anxiety through innovative approaches that blend psychedelics, ketamine, and wearable tech. He is also executive director of the nonprofit Board of Medicine, helping to set clinical safety guidelines for alternative medicines.
These show links may contain affiliate links. Third Wave receives a small percentage of the product price if you purchase through the above affiliate links.
products designed to support clarity, creativity, and emotional well-being. From Psilocybin
blends to LSD microdosing options, each formula is crafted with care, backed by science, and trusted by the Third Wave community.
Safe, intentional, and transformative — Golden Rule helps you feel more focused, connected, and aligned in your everyday life.
Want to experience the difference? Try Paul’s favorite microdosing picks — hand-selected
for performance, mood, and daily flow.
Get a lifetime discount of 10% with code THIRDWAVE at checkout.